MYCOPHENOLATE MOFETIL for Focal segmental glomerulosclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 177 adverse event reports in the FDA FAERS database where MYCOPHENOLATE MOFETIL was used for Focal segmental glomerulosclerosis.
Most Reported Side Effects for MYCOPHENOLATE MOFETIL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 13,474 | 18.0% | 2,365 | 4,340 |
| Drug ineffective | 7,729 | 10.4% | 1,415 | 2,667 |
| Product use in unapproved indication | 5,910 | 7.9% | 1,185 | 1,425 |
| Diarrhoea | 3,628 | 4.9% | 1,040 | 1,868 |
| Cytomegalovirus infection | 3,278 | 4.4% | 748 | 1,115 |
| Pneumonia | 3,017 | 4.0% | 1,321 | 1,641 |
| Pyrexia | 2,927 | 3.9% | 1,263 | 2,009 |
| Condition aggravated | 2,883 | 3.9% | 883 | 1,400 |
| Covid-19 | 2,706 | 3.6% | 525 | 1,868 |
| Transplant rejection | 2,500 | 3.4% | 254 | 723 |
| Infection | 2,411 | 3.2% | 1,409 | 1,233 |
| Fatigue | 2,366 | 3.2% | 982 | 1,384 |
| Treatment failure | 2,177 | 2.9% | 495 | 663 |
| Nausea | 2,167 | 2.9% | 674 | 1,153 |
| Acute kidney injury | 2,129 | 2.9% | 405 | 1,398 |
Other Indications for MYCOPHENOLATE MOFETIL
Immunosuppressant drug therapy (18,054)
Product used for unknown indication (10,317)
Immunosuppression (6,355)
Prophylaxis against graft versus host disease (6,298)
Prophylaxis against transplant rejection (6,062)
Renal transplant (5,874)
Systemic lupus erythematosus (2,645)
Liver transplant (1,409)
Lupus nephritis (1,393)
Heart transplant (1,227)
Other Drugs Used for Focal segmental glomerulosclerosis
RITUXIMAB (309)
CORTICOTROPIN (298)
TACROLIMUS (216)
CYCLOSPORINE (199)
PREDNISONE (189)
PREDNISOLONE (108)
METHYLPREDNISOLONE (89)
SPARSENTAN (57)
CYCLOPHOSPHAMIDE (49)
OBINUTUZUMAB (20)